Physician profile
Joann Reed
NPI 1568438885
$1,394.25
in general payments reported to CMS, 2019-2025
15 companies · $242 in 2025
The $242 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $334 · 2020: $60.96 · 2021: $410 · 2022: $259 · 2023: $69.77 · 2024: $18.08 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $330.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $348.79 | 2019-2022 | |
| Abbvie INC. | $147.06 | 2025 | |
| Allergan, INC. | $128.67 | 2019 | |
| Kala Pharmaceuticals, INC. | $124.54 | 2021 | |
| Aerie Pharmaceuticals, INC. | $118.88 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $111.13 | 2022-2023 | |
| Glaukos Corporation | $96.41 | 2019-2021 | |
| Dompe US, INC. | $95.30 | 2025 | Oxervate |
| Genentech USA, INC. | $81.04 | 2022 | |
| The Cameron-Ehlen Group, INC. | $52.16 | 2021 | |
| New World Medical,INC. | $21.17 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Rxsight INC | $18.08 | 2024 | Rxsight Injector Handpiece, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Sun Pharmaceutical Industries INC. | $16.86 | 2021 | |
| Bausch & Lomb Americas INC. | $14.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joann Reed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.